Observing how well Vericiguat works for patients with heart failure in Germany
Real World Outcomes of Patients Treated With Vericiguat in German Routine Care
This study looks at how well the heart medication Vericiguat works for people in Germany who have chronic heart failure with reduced ejection fraction.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bayer Industry-sponsored |
| Locations | 1 site (Wuppertal) |
| Trial ID | NCT06486844 on ClinicalTrials.gov |
What this trial studies
This observational study analyzes data from patients who have been newly treated with Vericiguat for chronic heart failure with reduced ejection fraction (HFrEF). The study does not involve any changes to participants' healthcare but focuses on understanding the effectiveness of Vericiguat in routine medical care. By examining real-world outcomes, the study aims to provide insights into the drug's performance in a clinical setting.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have been newly prescribed Vericiguat for chronic heart failure.
Not a fit: Patients who have not been prescribed Vericiguat or those under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of Vericiguat's effectiveness, potentially leading to improved treatment strategies for patients with heart failure.
How similar studies have performed: Other observational studies have shown success in evaluating the effectiveness of treatments for chronic heart failure, suggesting that this approach is valid and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with an initial prescription of Vericiguat (index date) according to ATC Code C01DX22. * At least 18 years or older on the initial prescription of Vericiguat. Exclusion Criteria: * No exclusion criteria for any population will be applied.
Where this trial is running
Wuppertal
- Bayer — Wuppertal, Germany (Recruiting)
Study contacts
- Study coordinator: Bayer Clinical Trials Contact
- Email: clinical-trials-contact@bayer.com
- Phone: (+)1-888-84 22937
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.